Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a site version update with no changes to study data or participant information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2; removed Revision: v3.4.1 and the lapse in government funding notice.SummaryDifference0.4%

- Check45 days agoChange DetectedAdded a government funding lapse notice and a status update for the NIH Clinical Center; introduced revision tag v3.4.1 and removed v3.4.0.SummaryDifference0.4%

- Check52 days agoChange DetectedThe page now displays a glossary option and updates the footer with QC-related metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedMinor site version update from Revision: v3.3.3 to v3.3.4; this change does not affect the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.